From: IMRT sparing of normal tissues in locoregional treatment of breast cancer
Treatment planning metrics | ||
---|---|---|
PTV | ||
V47.5 | 97.6% ± 1.5% | |
V53.5 | 5.9% ± 6.8% | |
Ipsilateral lung | ||
Mean dose | 10.2Gy ± 1.1Gy | |
V5 | 49.8% ± 10.4% | |
V20 | 16% ± 3.4% | |
Controlateral lung | ||
Mean dose | 5.3Gy ± 0.6Gy | |
V5 | 43.7% ± 8.9% | |
V20 | 0.5% ± 1.2% | |
Controlateral breast | ||
Mean dose | 4.0Gy ± 0.8Gy | |
V5 | 30.3% ± 15.7% | |
V10 | 2.3% ± 4.1% | |
Heart | Right side | Left side |
Mean dose | 7.8Gy ± 1.1Gy | 8.0Gy ± 1.2Gy |
V25 | 1.9% ± 1.4%* | 3.7% ± 1.9%* |
LAD artery | Right side | Left side |
Dose max | 33.3Gy ± 13.3Gy | 26.7Gy ± 15.7Gy |
Median dose | 13.3Gy ± 5.6Gy | 10.8Gy ± 7.8Gy |
RCA artery | Right side | Left side |
Dose max | 30.3Gy ± 8.6Gy | 27.0Gy ± 12.4Gy |
Median dose | 14.0Gy ± 4.9Gy | 12.4Gy ± 5.7Gy |
LCx artery | Right side | Left side |
Dose max | 8.6Gy ± 4.4Gy | 8.8Gy ± 3.2Gy |
Median dose | 4.4Gy ± 1.5Gy | 4.5Gy ± 1.7Gy |